

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 7.43679339 |
| 2 | cytidine catabolic process (GO:0006216) | 7.43679339 |
| 3 | cytidine deamination (GO:0009972) | 7.43679339 |
| 4 | positive regulation of monocyte chemotaxis (GO:0090026) | 6.71402758 |
| 5 | eosinophil chemotaxis (GO:0048245) | 6.61226736 |
| 6 | regulation of chronic inflammatory response (GO:0002676) | 6.60595941 |
| 7 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.59409447 |
| 8 | regulation of T cell tolerance induction (GO:0002664) | 6.48484496 |
| 9 | DNA deamination (GO:0045006) | 6.47897186 |
| 10 | regulation of activation of Janus kinase activity (GO:0010533) | 6.39739277 |
| 11 | regulation of mononuclear cell migration (GO:0071675) | 6.25794956 |
| 12 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.05718863 |
| 13 | eosinophil migration (GO:0072677) | 5.97622815 |
| 14 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.96598833 |
| 15 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.84036236 |
| 16 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 5.58539904 |
| 17 | regulation of macrophage chemotaxis (GO:0010758) | 5.53233566 |
| 18 | negative regulation of B cell proliferation (GO:0030889) | 5.51868057 |
| 19 | regulation of tolerance induction (GO:0002643) | 5.47780838 |
| 20 | regulation of regulatory T cell differentiation (GO:0045589) | 5.44249396 |
| 21 | regulation of T cell chemotaxis (GO:0010819) | 5.43618447 |
| 22 | positive regulation of T cell chemotaxis (GO:0010820) | 5.43618447 |
| 23 | negative regulation of organelle assembly (GO:1902116) | 5.41076391 |
| 24 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.26470284 |
| 25 | dendritic cell chemotaxis (GO:0002407) | 5.16803677 |
| 26 | positive regulation of tolerance induction (GO:0002645) | 5.08919627 |
| 27 | NIK/NF-kappaB signaling (GO:0038061) | 5.03849695 |
| 28 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.02473726 |
| 29 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.02473726 |
| 30 | macrophage chemotaxis (GO:0048246) | 5.00248322 |
| 31 | positive regulation of translational initiation (GO:0045948) | 4.79396599 |
| 32 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.77694611 |
| 33 | regulation of monocyte chemotaxis (GO:0090025) | 4.76649322 |
| 34 | positive regulation of T cell apoptotic process (GO:0070234) | 4.66321095 |
| 35 | negative regulation of T cell apoptotic process (GO:0070233) | 4.49529638 |
| 36 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.40185284 |
| 37 | * monocyte chemotaxis (GO:0002548) | 4.39136517 |
| 38 | actin nucleation (GO:0045010) | 4.29924018 |
| 39 | granulocyte activation (GO:0036230) | 4.22699838 |
| 40 | regulation of T cell migration (GO:2000404) | 4.16706145 |
| 41 | cellular response to interleukin-15 (GO:0071350) | 4.12385011 |
| 42 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.08931686 |
| 43 | response to interleukin-15 (GO:0070672) | 4.01717070 |
| 44 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.99865819 |
| 45 | positive regulation of leukocyte apoptotic process (GO:2000108) | 3.98814438 |
| 46 | positive regulation of protein sumoylation (GO:0033235) | 3.98067728 |
| 47 | nucleoside diphosphate catabolic process (GO:0009134) | 3.94221734 |
| 48 | dendritic cell migration (GO:0036336) | 3.93718808 |
| 49 | negative regulation by host of viral transcription (GO:0043922) | 3.89078594 |
| 50 | negative regulation of B cell activation (GO:0050869) | 3.87531624 |
| 51 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.87345177 |
| 52 | neutrophil activation (GO:0042119) | 3.80628976 |
| 53 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.79895120 |
| 54 | negative regulation of viral genome replication (GO:0045071) | 3.71421577 |
| 55 | positive regulation of T cell migration (GO:2000406) | 3.63940233 |
| 56 | positive regulation of lymphocyte migration (GO:2000403) | 3.59490246 |
| 57 | regulation of T cell apoptotic process (GO:0070232) | 3.56358889 |
| 58 | regulation of lymphocyte migration (GO:2000401) | 3.53423312 |
| 59 | regulation of cell killing (GO:0031341) | 3.51153911 |
| 60 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.49736648 |
| 61 | purine nucleoside diphosphate metabolic process (GO:0009135) | 3.48441587 |
| 62 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 3.48441587 |
| 63 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.40212970 |
| 64 | intestinal epithelial cell development (GO:0060576) | 3.39774260 |
| 65 | positive regulation of cell killing (GO:0031343) | 3.37080869 |
| 66 | negative regulation of chemokine production (GO:0032682) | 3.35846570 |
| 67 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.31262728 |
| 68 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.25866118 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.24429743 |
| 70 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.24276089 |
| 71 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.23345005 |
| 72 | T cell costimulation (GO:0031295) | 3.23336413 |
| 73 | negative regulation of interleukin-12 production (GO:0032695) | 3.22682966 |
| 74 | lymphocyte costimulation (GO:0031294) | 3.18680026 |
| 75 | negative regulation of T cell differentiation (GO:0045581) | 3.12745988 |
| 76 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.10303232 |
| 77 | negative regulation of cytokine biosynthetic process (GO:0042036) | 3.09650158 |
| 78 | negative regulation of T cell activation (GO:0050868) | 3.09087178 |
| 79 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.03509922 |
| 80 | activated T cell proliferation (GO:0050798) | 2.98876507 |
| 81 | positive regulation of type 2 immune response (GO:0002830) | 2.97763535 |
| 82 | cellular defense response (GO:0006968) | 2.97194478 |
| 83 | negative regulation of interleukin-2 production (GO:0032703) | 2.97145082 |
| 84 | T cell migration (GO:0072678) | 2.93950910 |
| 85 | cellular response to exogenous dsRNA (GO:0071360) | 2.92793063 |
| 86 | negative regulation of T cell proliferation (GO:0042130) | 2.92068537 |
| 87 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.91700425 |
| 88 | positive thymic T cell selection (GO:0045059) | 2.91459949 |
| 89 | regulation of immunoglobulin secretion (GO:0051023) | 2.90316170 |
| 90 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.88640305 |
| 91 | T cell mediated immunity (GO:0002456) | 2.87621001 |
| 92 | ribonucleoside diphosphate metabolic process (GO:0009185) | 2.86398561 |
| 93 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.85104378 |
| 94 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.83415638 |
| 95 | chemokine-mediated signaling pathway (GO:0070098) | 2.82210022 |
| 96 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.82120680 |
| 97 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.80334826 |
| 98 | positive regulation of hair cycle (GO:0042635) | 2.79733749 |
| 99 | positive regulation of hair follicle development (GO:0051798) | 2.79733749 |
| 100 | positive regulation of B cell differentiation (GO:0045579) | 2.76805088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.00972353 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.66888691 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.21198571 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.00228595 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.32754344 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.17888275 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.16482148 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.07320541 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.81652088 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.23791926 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.67788216 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.67252773 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.61554111 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.60165251 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.55358601 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.52008417 |
| 17 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.21258909 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.20525377 |
| 19 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.11612550 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03338975 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91817567 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 1.89336683 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81235990 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77581436 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.73565999 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66073698 |
| 27 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.65233414 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65116279 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65079174 |
| 30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63404368 |
| 31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62898352 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58972921 |
| 33 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55451886 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.54086244 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48723782 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.47731670 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.44702384 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41995797 |
| 39 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37144576 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35037142 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34552761 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.30772548 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25612607 |
| 44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.24082850 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.18247597 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.17280559 |
| 47 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17134226 |
| 48 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.15612534 |
| 49 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14429724 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13815779 |
| 51 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11394239 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10806860 |
| 53 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06044099 |
| 54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04723941 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04612557 |
| 56 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04278532 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02958134 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02790326 |
| 59 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.01374737 |
| 60 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.99441138 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99418092 |
| 62 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.99163347 |
| 63 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99009162 |
| 64 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98530246 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98311712 |
| 66 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.97088120 |
| 67 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.97088120 |
| 68 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.97088120 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95895395 |
| 70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95870225 |
| 71 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.95569081 |
| 72 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.94371822 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93235626 |
| 74 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92695784 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90507817 |
| 76 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.88616231 |
| 77 | P300_27268052_Chip-Seq_Bcells_Human | 0.88489216 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88251623 |
| 79 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87655941 |
| 80 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.85569282 |
| 81 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.82185470 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82119425 |
| 83 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81970918 |
| 84 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.79390931 |
| 85 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79118993 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.78585510 |
| 87 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.77840940 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77195823 |
| 89 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.77023219 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76876635 |
| 91 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76308301 |
| 92 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.75265070 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74519206 |
| 94 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.74454592 |
| 95 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.74404021 |
| 96 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.74178344 |
| 97 | GATA3_26560356_Chip-Seq_TH1_Human | 0.74166802 |
| 98 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.72816093 |
| 99 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.70763344 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.69591108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.65918468 |
| 2 | MP0001853_heart_inflammation | 3.83441007 |
| 3 | MP0001873_stomach_inflammation | 3.40319023 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.36903705 |
| 5 | MP0006082_CNS_inflammation | 3.31871263 |
| 6 | MP0009785_altered_susceptibility_to | 3.19785565 |
| 7 | MP0003045_fibrosis | 2.92545680 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 2.84109854 |
| 9 | MP0010307_abnormal_tumor_latency | 2.67249544 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.64594423 |
| 11 | MP0009333_abnormal_splenocyte_physiolog | 2.62907132 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.60330078 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.50594607 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.48916825 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.47815458 |
| 16 | MP0005025_abnormal_response_to | 2.41527728 |
| 17 | MP0001800_abnormal_humoral_immune | 2.37599372 |
| 18 | MP0002723_abnormal_immune_serum | 2.37186351 |
| 19 | MP0002405_respiratory_system_inflammati | 2.33037839 |
| 20 | MP0002638_abnormal_pupillary_reflex | 2.21311622 |
| 21 | MP0003075_altered_response_to | 2.18304282 |
| 22 | MP0003436_decreased_susceptibility_to | 2.11596720 |
| 23 | MP0002419_abnormal_innate_immunity | 2.05247306 |
| 24 | MP0003011_delayed_dark_adaptation | 2.03923970 |
| 25 | MP0005387_immune_system_phenotype | 2.03114339 |
| 26 | MP0001790_abnormal_immune_system | 2.03114339 |
| 27 | MP0000685_abnormal_immune_system | 2.02839306 |
| 28 | MP0002420_abnormal_adaptive_immunity | 2.02414243 |
| 29 | MP0001819_abnormal_immune_cell | 2.02095737 |
| 30 | MP0002452_abnormal_antigen_presenting | 2.01158088 |
| 31 | MP0002139_abnormal_hepatobiliary_system | 1.93699028 |
| 32 | MP0005310_abnormal_salivary_gland | 1.87705946 |
| 33 | MP0001188_hyperpigmentation | 1.87658239 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.80920430 |
| 35 | MP0000569_abnormal_digit_pigmentation | 1.71517470 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.68243075 |
| 37 | MP0009840_abnormal_foam_cell | 1.66528484 |
| 38 | MP0003303_peritoneal_inflammation | 1.64268532 |
| 39 | MP0001905_abnormal_dopamine_level | 1.63933094 |
| 40 | MP0009764_decreased_sensitivity_to | 1.63891204 |
| 41 | MP0002398_abnormal_bone_marrow | 1.61116117 |
| 42 | MP0000716_abnormal_immune_system | 1.59968557 |
| 43 | MP0005165_increased_susceptibility_to | 1.53868474 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.41507552 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.39809187 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.35452153 |
| 47 | MP0003448_altered_tumor_morphology | 1.34895240 |
| 48 | MP0000343_altered_response_to | 1.34601039 |
| 49 | MP0002429_abnormal_blood_cell | 1.29616471 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.28959856 |
| 51 | MP0002090_abnormal_vision | 1.28211586 |
| 52 | MP0002722_abnormal_immune_system | 1.27800846 |
| 53 | MP0002933_joint_inflammation | 1.26546437 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.25651635 |
| 55 | MP0000920_abnormal_myelination | 1.24266526 |
| 56 | MP0008469_abnormal_protein_level | 1.23023086 |
| 57 | MP0009765_abnormal_xenobiotic_induced | 1.22207043 |
| 58 | MP0005365_abnormal_bile_salt | 1.17267693 |
| 59 | MP0003786_premature_aging | 1.13705086 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.13505466 |
| 61 | MP0003724_increased_susceptibility_to | 1.13431412 |
| 62 | MP0009763_increased_sensitivity_to | 1.11564478 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.11297711 |
| 64 | MP0003567_abnormal_fetal_cardiomyocyte | 1.09422352 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.07879795 |
| 66 | MP0008007_abnormal_cellular_replicative | 1.04209772 |
| 67 | MP0004947_skin_inflammation | 1.03329110 |
| 68 | MP0003866_abnormal_defecation | 1.03199674 |
| 69 | MP0005166_decreased_susceptibility_to | 0.98921927 |
| 70 | MP0001533_abnormal_skeleton_physiology | 0.98710473 |
| 71 | MP0000604_amyloidosis | 0.97302310 |
| 72 | MP0005623_abnormal_meninges_morphology | 0.94629615 |
| 73 | MP0005360_urolithiasis | 0.94104088 |
| 74 | MP0005174_abnormal_tail_pigmentation | 0.88481796 |
| 75 | MP0008004_abnormal_stomach_pH | 0.86096500 |
| 76 | MP0003172_abnormal_lysosome_physiology | 0.84847312 |
| 77 | MP0002168_other_aberrant_phenotype | 0.83559951 |
| 78 | MP0009278_abnormal_bone_marrow | 0.82478760 |
| 79 | MP0004381_abnormal_hair_follicle | 0.82411215 |
| 80 | MP0000371_diluted_coat_color | 0.82380046 |
| 81 | MP0002998_abnormal_bone_remodeling | 0.81276593 |
| 82 | MP0001663_abnormal_digestive_system | 0.78442556 |
| 83 | MP0001919_abnormal_reproductive_system | 0.71234346 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.70199038 |
| 85 | MP0001968_abnormal_touch/_nociception | 0.70017314 |
| 86 | MP0008873_increased_physiological_sensi | 0.69722098 |
| 87 | MP0006035_abnormal_mitochondrial_morpho | 0.68136477 |
| 88 | MP0005164_abnormal_response_to | 0.61086327 |
| 89 | MP0009643_abnormal_urine_homeostasis | 0.60894877 |
| 90 | MP0003690_abnormal_glial_cell | 0.58477702 |
| 91 | MP0002019_abnormal_tumor_incidence | 0.58413535 |
| 92 | MP0000858_altered_metastatic_potential | 0.56713958 |
| 93 | MP0003137_abnormal_impulse_conducting | 0.55874026 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.53893093 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.51261801 |
| 96 | MP0001186_pigmentation_phenotype | 0.50487970 |
| 97 | MP0006054_spinal_hemorrhage | 0.49964067 |
| 98 | MP0005390_skeleton_phenotype | 0.49317941 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.49079856 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.48602348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.42444838 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.45304708 |
| 3 | IgG deficiency (HP:0004315) | 4.52896110 |
| 4 | Recurrent cutaneous fungal infections (HP:0011370) | 4.41288033 |
| 5 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.41288033 |
| 6 | Abnormality of the prostate (HP:0008775) | 4.20855742 |
| 7 | Severe combined immunodeficiency (HP:0004430) | 4.15130745 |
| 8 | Abnormality of T cells (HP:0002843) | 4.12095145 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.05475327 |
| 10 | Obstructive lung disease (HP:0006536) | 4.05475327 |
| 11 | Purpura (HP:0000979) | 4.05253354 |
| 12 | Stomatitis (HP:0010280) | 3.84377852 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.73538324 |
| 14 | Tongue fasciculations (HP:0001308) | 3.61118326 |
| 15 | Ureteral stenosis (HP:0000071) | 3.60369521 |
| 16 | Combined immunodeficiency (HP:0005387) | 3.58530180 |
| 17 | Prolonged neonatal jaundice (HP:0006579) | 3.57262321 |
| 18 | Thyroiditis (HP:0100646) | 3.39901775 |
| 19 | Meningitis (HP:0001287) | 3.39747572 |
| 20 | Recurrent bronchitis (HP:0002837) | 3.37924743 |
| 21 | Chronic diarrhea (HP:0002028) | 3.31371179 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 3.31032345 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.31032345 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.31032345 |
| 25 | Muscle fibrillation (HP:0010546) | 3.26534386 |
| 26 | Ureteral obstruction (HP:0006000) | 3.25179223 |
| 27 | Agammaglobulinemia (HP:0004432) | 3.23687138 |
| 28 | Gangrene (HP:0100758) | 3.22436808 |
| 29 | Hypoplasia of the thymus (HP:0000778) | 3.17184002 |
| 30 | Type I transferrin isoform profile (HP:0003642) | 3.15588327 |
| 31 | Hemoptysis (HP:0002105) | 3.12417940 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.08312908 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 3.07807184 |
| 34 | Encephalitis (HP:0002383) | 3.06208188 |
| 35 | Recurrent skin infections (HP:0001581) | 3.05384200 |
| 36 | Pulmonary infiltrates (HP:0002113) | 3.01922961 |
| 37 | Methylmalonic aciduria (HP:0012120) | 3.01682111 |
| 38 | Hemiplegia (HP:0002301) | 2.94123711 |
| 39 | Abnormality of the pleura (HP:0002103) | 2.89059423 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.85357724 |
| 41 | Abnormal albumin level (HP:0012116) | 2.84446167 |
| 42 | Hypoalbuminemia (HP:0003073) | 2.84446167 |
| 43 | Agitation (HP:0000713) | 2.81577017 |
| 44 | Abnormality of lateral ventricle (HP:0030047) | 2.80505324 |
| 45 | Increased cerebral lipofuscin (HP:0011813) | 2.77930845 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.77536928 |
| 47 | Cutaneous melanoma (HP:0012056) | 2.73815713 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.71739808 |
| 49 | Vasculitis (HP:0002633) | 2.71667568 |
| 50 | Chest pain (HP:0100749) | 2.70464395 |
| 51 | Bifid tongue (HP:0010297) | 2.69365147 |
| 52 | Squamous cell carcinoma (HP:0002860) | 2.68494972 |
| 53 | Acute hepatic failure (HP:0006554) | 2.67305342 |
| 54 | Pulmonary embolism (HP:0002204) | 2.66437635 |
| 55 | Recurrent bacterial skin infections (HP:0005406) | 2.63434048 |
| 56 | Pulmonary fibrosis (HP:0002206) | 2.59439750 |
| 57 | Global brain atrophy (HP:0002283) | 2.55646434 |
| 58 | Increased IgM level (HP:0003496) | 2.54742508 |
| 59 | Leukocytosis (HP:0001974) | 2.54072496 |
| 60 | Recurrent fungal infections (HP:0002841) | 2.53276890 |
| 61 | Abnormality of the pericardium (HP:0001697) | 2.52294295 |
| 62 | Myositis (HP:0100614) | 2.46010504 |
| 63 | Abnormality of the anterior horn cell (HP:0006802) | 2.43817396 |
| 64 | Degeneration of anterior horn cells (HP:0002398) | 2.43817396 |
| 65 | Progressive external ophthalmoplegia (HP:0000590) | 2.43728803 |
| 66 | Recurrent viral infections (HP:0004429) | 2.43129589 |
| 67 | Polyneuropathy (HP:0001271) | 2.39990366 |
| 68 | Abnormality of midbrain morphology (HP:0002418) | 2.39452454 |
| 69 | Molar tooth sign on MRI (HP:0002419) | 2.39452454 |
| 70 | Hypoproteinemia (HP:0003075) | 2.36410457 |
| 71 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.35188320 |
| 72 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.35188320 |
| 73 | Abnormal protein glycosylation (HP:0012346) | 2.35188320 |
| 74 | Abnormal glycosylation (HP:0012345) | 2.35188320 |
| 75 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.30525176 |
| 76 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.30525176 |
| 77 | Thrombocytosis (HP:0001894) | 2.29520965 |
| 78 | Abolished electroretinogram (ERG) (HP:0000550) | 2.25140602 |
| 79 | Pancreatitis (HP:0001733) | 2.25083996 |
| 80 | Skin rash (HP:0000988) | 2.24252232 |
| 81 | Glomerulopathy (HP:0100820) | 2.23949914 |
| 82 | Abnormality of male internal genitalia (HP:0000022) | 2.23774475 |
| 83 | Periodontitis (HP:0000704) | 2.22864581 |
| 84 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.22473747 |
| 85 | Periorbital edema (HP:0100539) | 2.18934455 |
| 86 | Malignant hyperthermia (HP:0002047) | 2.17396078 |
| 87 | Methylmalonic acidemia (HP:0002912) | 2.17036227 |
| 88 | Increased serum ferritin (HP:0003281) | 2.14942472 |
| 89 | Petechiae (HP:0000967) | 2.14717243 |
| 90 | Acrocyanosis (HP:0001063) | 2.12370227 |
| 91 | Mediastinal lymphadenopathy (HP:0100721) | 2.12029468 |
| 92 | Abnormality of eosinophils (HP:0001879) | 2.11365766 |
| 93 | Facial edema (HP:0000282) | 2.10685694 |
| 94 | Zonular cataract (HP:0010920) | 2.10344967 |
| 95 | Retrobulbar optic neuritis (HP:0100654) | 2.08809702 |
| 96 | Optic neuritis (HP:0100653) | 2.08809702 |
| 97 | Premature loss of primary teeth (HP:0006323) | 2.05128448 |
| 98 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.00125884 |
| 99 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.98628688 |
| 100 | Joint swelling (HP:0001386) | 1.98223779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPKAPK3 | 3.90494599 |
| 2 | FES | 3.48332953 |
| 3 | TYRO3 | 2.86232763 |
| 4 | KDR | 2.74509847 |
| 5 | TBK1 | 2.62591254 |
| 6 | BCKDK | 2.51218067 |
| 7 | SCYL2 | 2.50512796 |
| 8 | IKBKE | 2.04548901 |
| 9 | TXK | 11.0809125 |
| 10 | CSK | 1.97100422 |
| 11 | IRAK3 | 1.92639988 |
| 12 | IKBKB | 1.63840493 |
| 13 | BLK | 1.62057340 |
| 14 | JAK3 | 1.48329476 |
| 15 | PIK3CG | 1.48130308 |
| 16 | TESK2 | 1.44500384 |
| 17 | TNK2 | 1.42993167 |
| 18 | ZAP70 | 1.40617612 |
| 19 | GRK7 | 1.33838958 |
| 20 | LCK | 1.33048534 |
| 21 | ACVR1B | 1.26813803 |
| 22 | SYK | 1.25828251 |
| 23 | ITK | 1.25026123 |
| 24 | BUB1 | 1.25023934 |
| 25 | ADRBK2 | 1.23130646 |
| 26 | DAPK1 | 1.21239085 |
| 27 | MAP3K14 | 1.19016692 |
| 28 | MAPK7 | 1.18541866 |
| 29 | MAP4K1 | 1.13603858 |
| 30 | RIPK4 | 1.13478938 |
| 31 | CSF1R | 1.12886407 |
| 32 | FGR | 1.05232671 |
| 33 | JAK2 | 1.04408627 |
| 34 | PRKCQ | 1.03831010 |
| 35 | PDGFRB | 0.98409528 |
| 36 | LYN | 0.97691292 |
| 37 | LIMK1 | 0.91607237 |
| 38 | CAMKK2 | 0.91578335 |
| 39 | TLK1 | 0.91388592 |
| 40 | CAMK4 | 0.89649519 |
| 41 | IRAK4 | 0.77366062 |
| 42 | TESK1 | 0.69694749 |
| 43 | MINK1 | 0.68509206 |
| 44 | PIM1 | 0.67554287 |
| 45 | PRKD3 | 0.67235388 |
| 46 | MARK3 | 0.66482581 |
| 47 | BMPR2 | 0.66005527 |
| 48 | MATK | 0.65485150 |
| 49 | TEC | 0.65217663 |
| 50 | FYN | 0.61247756 |
| 51 | TAOK3 | 0.60352638 |
| 52 | VRK1 | 0.59202796 |
| 53 | VRK2 | 0.59155810 |
| 54 | TYK2 | 0.56822647 |
| 55 | CHUK | 0.56539177 |
| 56 | PRKCI | 0.55817047 |
| 57 | BTK | 0.55574689 |
| 58 | TGFBR2 | 0.53699826 |
| 59 | MST4 | 0.51235282 |
| 60 | GRK6 | 0.50018800 |
| 61 | ATR | 0.49445804 |
| 62 | CDK4 | 0.47891406 |
| 63 | PIM2 | 0.47525195 |
| 64 | CAMK2G | 0.41657955 |
| 65 | DDR2 | 0.41584625 |
| 66 | IRAK2 | 0.39887862 |
| 67 | NME2 | 0.39526593 |
| 68 | TAOK2 | 0.38562914 |
| 69 | CAMK2A | 0.35893295 |
| 70 | CDK19 | 0.32332788 |
| 71 | AURKA | 0.31960450 |
| 72 | ABL1 | 0.30199855 |
| 73 | ABL2 | 0.28508481 |
| 74 | PRKCG | 0.26123202 |
| 75 | INSR | 0.25997166 |
| 76 | CSNK1G3 | 0.24270387 |
| 77 | MAP2K6 | 0.24105012 |
| 78 | DYRK1B | 0.23929521 |
| 79 | MAPKAPK2 | 0.23551168 |
| 80 | CSNK1A1L | 0.22988205 |
| 81 | STK11 | 0.22559228 |
| 82 | CAMK1D | 0.22353091 |
| 83 | STK10 | 0.21852706 |
| 84 | MYLK | 0.21027200 |
| 85 | JAK1 | 0.17894388 |
| 86 | PBK | 0.17084211 |
| 87 | RIPK1 | 0.16643801 |
| 88 | HIPK2 | 0.16276415 |
| 89 | HCK | 0.15906226 |
| 90 | MAPK4 | 0.15454497 |
| 91 | DAPK3 | 0.15149832 |
| 92 | MAPK11 | 0.15063037 |
| 93 | MAP3K12 | 0.14843377 |
| 94 | SRC | 0.14788373 |
| 95 | IGF1R | 0.14035445 |
| 96 | CDC42BPA | 0.13578875 |
| 97 | FGFR1 | 0.13125048 |
| 98 | MAP3K9 | 0.13011011 |
| 99 | PAK1 | 0.12307235 |
| 100 | GRK1 | 0.12279272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.78026964 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.22534112 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.73952172 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.71452831 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.40806705 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.20646820 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.11342557 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.61752400 |
| 9 | Prion diseases_Homo sapiens_hsa05020 | 2.47286662 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.45553725 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.41640971 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.32678145 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.30813620 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.24338534 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.16850486 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.15364141 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.11501446 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.00134366 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.92603788 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.87908489 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.85270004 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.75861107 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.53445820 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47572393 |
| 25 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.46077860 |
| 26 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.38633565 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28377964 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26385818 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24212413 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.23891486 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.11968327 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07660336 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.07052371 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04342340 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02303191 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 1.00484746 |
| 37 | Malaria_Homo sapiens_hsa05144 | 0.96562301 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 0.96248368 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 0.95668622 |
| 40 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93368628 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92820642 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 0.92618762 |
| 43 | Proteasome_Homo sapiens_hsa03050 | 0.89851418 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81552393 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80080667 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72502988 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 0.69128313 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67873721 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 0.67352871 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66826452 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65862359 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63220069 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62832938 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57998655 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 0.57175763 |
| 56 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55162563 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55135357 |
| 58 | Homologous recombination_Homo sapiens_hsa03440 | 0.54361813 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54277144 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.50992434 |
| 61 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47926155 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46915482 |
| 63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44222578 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41714385 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.40364951 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39806684 |
| 67 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.38950036 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38870896 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38403820 |
| 70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37457519 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36187092 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34607852 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.34013905 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33396882 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33210367 |
| 76 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.31170726 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30046954 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29239926 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26483141 |
| 80 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.26429804 |
| 81 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.25256377 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23282083 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.23112325 |
| 84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.22620115 |
| 85 | Phototransduction_Homo sapiens_hsa04744 | 0.22230704 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.21684773 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.18110153 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16159237 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16051825 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.12690818 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.12568577 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.12426757 |
| 93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.11473158 |
| 94 | Parkinsons disease_Homo sapiens_hsa05012 | 0.11370306 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.10723594 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.10472577 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.08792311 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.06394362 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.06280930 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.05895400 |

